These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 30972078)

  • 1. Advances in mRNA Vaccines for Infectious Diseases.
    Zhang C; Maruggi G; Shan H; Li J
    Front Immunol; 2019; 10():594. PubMed ID: 30972078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
    Maruggi G; Zhang C; Li J; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):757-772. PubMed ID: 30803823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination.
    Tombácz I; Weissman D; Pardi N
    Methods Mol Biol; 2021; 2197():13-31. PubMed ID: 32827130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.
    Le T; Sun C; Chang J; Zhang G; Yin X
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA vaccines against infectious diseases and future direction.
    Aleem MT; Munir F; Shakoor A; Gao F
    Int Immunopharmacol; 2024 Jun; 135():112320. PubMed ID: 38788451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA vaccines for infectious diseases: principles, delivery and clinical translation.
    Chaudhary N; Weissman D; Whitehead KA
    Nat Rev Drug Discov; 2021 Nov; 20(11):817-838. PubMed ID: 34433919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20-22 April 2021.
    Liu MA; Zhou T; Sheets RL; Meyer H; Knezevic I
    Emerg Microbes Infect; 2022 Dec; 11(1):384-391. PubMed ID: 35001848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for effective naked-DNA vaccination against infectious diseases.
    Chiarella P; Massi E; De Robertis M; Fazio VM; Signori E
    Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):93-101. PubMed ID: 18673122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches in vaccine development.
    Leclerc C
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field.
    Majhen D; Calderon H; Chandra N; Fajardo CA; Rajan A; Alemany R; Custers J
    Hum Gene Ther; 2014 Apr; 25(4):301-17. PubMed ID: 24580050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current progress in the development of prophylactic and therapeutic vaccines.
    Li T; Qian C; Gu Y; Zhang J; Li S; Xia N
    Sci China Life Sci; 2023 Apr; 66(4):679-710. PubMed ID: 36469218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New adjuvants for human vaccines.
    Mbow ML; De Gregorio E; Valiante NM; Rappuoli R
    Curr Opin Immunol; 2010 Jun; 22(3):411-6. PubMed ID: 20466528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New vaccines against infectious diseases].
    Kraehenbuhl JP
    Rev Med Suisse Romande; 1997 Dec; 117(12):929-30. PubMed ID: 9481164
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress on mRNA vaccine for the prevention of major infectious diseases in humans and animals].
    Gao JQ; Zhao XJ; Hua JL
    Sheng Li Xue Bao; 2023 Oct; 75(5):647-658. PubMed ID: 37909136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of vaccination against infectious disease in children in 2003.
    Lajeunesse M
    Expert Rev Vaccines; 2003 Oct; 2(5):611-4. PubMed ID: 14711322
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Epitope Discovery and Synthetic Vaccine Design.
    Palatnik-de-Sousa CB; Soares IS; Rosa DS
    Front Immunol; 2018; 9():826. PubMed ID: 29720983
    [No Abstract]   [Full Text] [Related]  

  • 17. Nucleic acid vaccination strategies against infectious diseases.
    Marć MA; Domínguez-Álvarez E; Gamazo C
    Expert Opin Drug Deliv; 2015; 12(12):1851-65. PubMed ID: 26365499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases.
    Yang L; Tang L; Zhang M; Liu C
    Front Immunol; 2022; 13():896958. PubMed ID: 35928814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical progress and challenges of mRNA vaccines.
    Yu MZ; Wang NN; Zhu JQ; Lin YX
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1894. PubMed ID: 37096256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle Vaccines Against Infectious Diseases.
    Pati R; Shevtsov M; Sonawane A
    Front Immunol; 2018; 9():2224. PubMed ID: 30337923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.